ERBB2 and neoplasm: Antibody-mediated depletion of Tregs concomitant with Lm-based vaccination against Her2 resulted in enhanced anti-tumor efficacy, therefore, providing a possible therapeutic avenue for improved efficacy in the clinic (Singh and Paterson, 2007b).